S3F0 (S3F0) News
Follow S3F0 (S3F0) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Santhera Pharmaceuticals H1 2026 Earnings Call Is Live
Santhera Pharmaceuticals's earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.
EARNINGS | Sep 30, 2026, 11:57 AM UTC
L
Switzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Sep 30, 2026, 05:11 AM UTC
H
Santhera Pharmaceuticals Holding AG (S3F0) H1 Revenue CHF 48.3M; Guides CHF 80—90M FY
Santhera reported H1 2026 revenue of CHF 48.3M and a net loss of CHF -21.5M, and reiterated 2026 revenue guidance of CHF 80—90M with opex of CHF 50—55M.Material DetailsContext by AI AnalystThis is mid-cycle confirmation
EARNINGS | Sep 30, 2026, 05:01 AM UTC